NYBA
New York Biotechnology Association
Home
 
 
New York Biotechnology Association Announces Search For New Executive Director
The New York Biotechnology Association (NYBA), a not-for-profit trade...
06/ 29/ 2007

More…
Powered by Business Wire
New York Biotechnology Headlines
Today is July 24, 2008. All times in Eastern Daylight Time.
07/24/2008 - 08:30 AM
Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by US FDA
07/24/2008 - 07:00 AM
Antigenics to Report Second Quarter 2008 Financial Results on July 31, 2008; Conference Call to Follow
07/24/2008 - 02:00 AM
Elan Reports Second Quarter 2008 Financial Results
07/23/2008 - 04:30 PM
Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject(TM) Compared to the Rapid-acting Analog Humalog(R) and Regular Human Insulin in Healthy Volunteers and Compared to Regular Human Insulin in Patients with Type 1 Diabetes
07/23/2008 - 04:05 PM
OSI Pharmaceuticals Announces Second Quarter 2008 Financial Results
07/23/2008 - 12:24 PM
Research and Markets: Recent Report 'Chugai Pharma Partnering Guide 2008' Provides A Firm Basis for Initial Due Diligence into Chugai as A Prospective Partner Company
07/23/2008 - 10:00 AM
Vertical*i Achieves Record Growth in Sales Orders for the First Half of 2008
07/23/2008 - 08:30 AM
Photo
Drug Topics Examines the Emerging Arm of Innovation at Retail Pharmacies
07/23/2008 - 08:00 AM
Allos Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
07/23/2008 - 08:00 AM
The Medicines Company Reports Second Quarter and First Half 2008 Financial Results and Raises Full Year Top Line Guidance
07/23/2008 - 06:30 AM
AngioDynamics Appoints Vice President of International IRE Sales
07/22/2008 - 04:00 PM
BioScrip to Present at BMO Capital Markets' Focus on Healthcare Conference
07/22/2008 - 10:26 AM
Compliance for Life(TM) Medication Dosing Reminders Go Global
07/22/2008 - 03:06 AM
PhiloGene, Inc. Announces that VEGFb(TM) has been Granted Orphan Drug Designation by the FDA for the Treatment of Advanced Melanoma
07/22/2008 - 02:00 AM
Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results
07/21/2008 - 11:19 AM
Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals and $3.0 Million Financing
07/21/2008 - 10:18 AM
Vyteris, Inc. Receives $2.5 Million Loan from Ferring Pharmaceuticals, Inc.
07/21/2008 - 09:00 AM
Lakewood Pathology Associates Announces New Name
07/21/2008 - 09:00 AM
AMRI Expands Laboratory Capacity in Singapore; Adds In Vitro Biology Laboratory
07/21/2008 - 07:00 AM
VioQuest Pharmaceuticals Appoints Christopher P. Schnittker, CPA, as Chief Financial Officer
07/21/2008 - 07:00 AM
IMS Health Delivers 12 Percent Revenue and 11 Percent Operating Income Growth in Second Quarter
07/18/2008 - 04:30 PM
ImClone Systems to Host Second Quarter 2008 Financial Results Conference Call
07/18/2008 - 02:14 PM
The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade
07/18/2008 - 11:07 AM
Discover the Relevance of Hippocampal Place Fields to Learning and Memory
07/18/2008 - 08:00 AM
Omrix Biopharmaceuticals Announces Second Quarter 2008 Financial Results Date and Conference Call
1 2
 
NEXT »
Terms of Use   |   ©2008 Business Wire
 
   
  © 2007 New York Biotechnology Association HOME | ABOUT NYBA | CONTACT US | NOTICES | SITE MAP Website by Axxiem